Abel Hall LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Abel Hall LLC's AMGN Position: Q3 2026 in Review
Abel Hall LLC reduced its Amgen (AMGN) stake by 0.06% in Q3 2026, selling an estimated $399 and leaving 1,569 shares worth $661K. The position accounts for 0.12% of the portfolio, ranked #144.
Abel Hall LLC first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $855K in Q1 2026. 1,235 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Abel Hall LLC held 1,569 shares of Amgen worth $661K as of Q3 2026.
- Abel Hall LLC sold 1 Amgen share in Q3 2026, an estimated $399.
- Amgen made up 0.12% of Abel Hall LLC's portfolio in Q3 2026, its #144 holding.
- Abel Hall LLC first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
- Abel Hall LLC's Amgen position peaked at $855K in Q1 2026.
- 1,235 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.